Cargando…
Tumor-Derived Suppressor of Fused Mutations Reveal Hedgehog Pathway Interactions
The Hedgehog pathway is a potent regulator of cellular growth and plays a central role in the development of many cancers including basal cell carcinoma (BCC). The majority of BCCs arise from mutations in the Patched receptor resulting in constitutive activation of the Hedgehog pathway. Secondary dr...
Autores principales: | Urman, Nicole M., Mirza, Amar, Atwood, Scott X., Whitson, Ramon J., Sarin, Kavita Y., Tang, Jean Y., Oro, Anthony E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5193403/ https://www.ncbi.nlm.nih.gov/pubmed/28030567 http://dx.doi.org/10.1371/journal.pone.0168031 |
Ejemplares similares
-
Non-canonical hedgehog pathway activation by MKL1/SRF promotes
drug-resistance in basal cell carcinomas
por: Whitson, Ramon J., et al.
Publicado: (2018) -
AP-1 and TGFß cooperativity drives non-canonical Hedgehog signaling in resistant basal cell carcinoma
por: Yao, Catherine D., et al.
Publicado: (2020) -
Rolling the genetic dice: neutral and deleterious Smoothened mutations in drug-resistant basal cell carcinoma
por: Atwood, Scott X., et al.
Publicado: (2015) -
Hedgehog pathway inhibition and the race against tumor evolution
por: Atwood, Scott X., et al.
Publicado: (2012) -
Protein phosphatase 4 promotes Hedgehog signaling through dephosphorylation of Suppressor of fused
por: Liao, Hengqing, et al.
Publicado: (2020)